JETEMA Co. Ltd
JETEMA, Co., Ltd., a bio venture company, engages in the research and development of medicines and medical devices. It offers clostridium botulinum toxins, fillers, lifting threads for medical treatment, elastin and collagen stimulate solution under Ecolla, and healthy skin care under vitten brand names. The company also provides skin care hyaluronic acid masks. JETEMA, Co., Ltd. was founded in 2… Read more
JETEMA Co. Ltd (216080) - Total Assets
Latest total assets as of September 2025: ₩218.30 Billion KRW
Based on the latest financial reports, JETEMA Co. Ltd (216080) holds total assets worth ₩218.30 Billion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
JETEMA Co. Ltd - Total Assets Trend (2017–2024)
This chart illustrates how JETEMA Co. Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
JETEMA Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
JETEMA Co. Ltd's total assets of ₩218.30 Billion consist of 22.9% current assets and 77.1% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩23.10 Billion | 10.4% |
| Accounts Receivable | ₩5.29 Billion | 2.4% |
| Inventory | ₩18.97 Billion | 8.5% |
| Property, Plant & Equipment | ₩108.13 Billion | 48.6% |
| Intangible Assets | ₩15.38 Billion | 6.9% |
| Goodwill | ₩1.19 Billion | 0.5% |
Asset Composition Trend (2017–2024)
This chart illustrates how JETEMA Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: JETEMA Co. Ltd's current assets represent 22.9% of total assets in 2024, a decrease from 35.2% in 2017.
- Cash Position: Cash and equivalents constituted 10.4% of total assets in 2024, up from 0.0% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 0.0% in 2017.
- Asset Diversification: The largest asset category is property, plant & equipment at 48.6% of total assets.
JETEMA Co. Ltd Competitors by Total Assets
Key competitors of JETEMA Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
JETEMA Co. Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - JETEMA Co. Ltd generates 0.31x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - JETEMA Co. Ltd is currently not profitable relative to its asset base.
JETEMA Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.41 | 0.42 | 1.72 |
| Quick Ratio | 0.23 | 0.29 | 1.34 |
| Cash Ratio | 0.00 | 0.18 | 0.00 |
| Working Capital | ₩-56.70 Billion | ₩ -86.79 Billion | ₩ 11.37 Billion |
JETEMA Co. Ltd - Advanced Valuation Insights
This section examines the relationship between JETEMA Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.67 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -8.8% |
| Total Assets | ₩222.72 Billion |
| Market Capitalization | $148.99 Million USD |
Valuation Analysis
Below Book Valuation: The market values JETEMA Co. Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: JETEMA Co. Ltd's assets decreased by 8.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for JETEMA Co. Ltd (2017–2024)
The table below shows the annual total assets of JETEMA Co. Ltd from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩222.72 Billion | -8.81% |
| 2023-12-31 | ₩244.23 Billion | +29.67% |
| 2022-12-31 | ₩188.35 Billion | +27.33% |
| 2021-12-31 | ₩147.93 Billion | +121.25% |
| 2020-12-31 | ₩66.86 Billion | +7.34% |
| 2019-12-31 | ₩62.29 Billion | +21.45% |
| 2018-12-31 | ₩51.29 Billion | +170.37% |
| 2017-12-31 | ₩18.97 Billion | -- |